This study is currently recruiting participants.
National Cancer Institute (NCI)
Type: Participants currently recruited/enrolled Gender: Male & Female Min Age: 2 Years Max Age: N/A
Referral Letter Required
CD-19 expressing tumor; CD-22 Expressing Tumor; Adaptive Immunotherapy; Caregivers; Natural History
Acute Lymphoid Leukemia; B-Cell Leukemia; Lymphoma, Non-Hodgkin; Neoplasms; B-Cell Lymphoma
National Cancer Institute
Doctors want to learn more about what it is like to receive CAR T-cell cancer therapy. Most of what they know comes from what a person s doctors or nurses report about their symptoms. Researchers think that this may not fully describe what this treatment is like for people and their families. They want to help people and their families know what to expect when they go through treatment with CAR T-cells.
To better understand what it is like for young people to be treated with CAR T-cell therapies.
People ages 8 to 25 or caregivers of a child aged 2 to 25 who will be treated with CAR T-cell therapy at the National Cancer Institute - Pediatric Oncology Branch.
Participants will be screened with a review of their medical records.
Participants will be enrolled on the CAR T PROs study. This will include up to 10 surveys. The surveys will take 10 to 30 minutes each. It will also include one interview. The interview will take about 30 to 60 minutes. Surveys can be done on paper or an electronic version using a secure survey tool.
For caregivers, surveys will be completed by one caregiver at each time point. The
interview is open to both caregivers, if this applies.
During the study, participants might have to go to the hospital for side effects of the CAR T-cell therapy. If this happens, they may be asked to complete another survey at that time.
Interviews with participants will be audiotaped or digitally recorded.
Participants will be in the study for one year.
--Back to Top--
Eligibility: - Patient Participants ages 2-25 years old -- Any cancer diagnosis -- Scheduled to receive CAR T cell therapy - Caregiver Participants -- Primary caregiver of a patient 2 to 25 years who is scheduled to receive CAR T cell therapy - Speak and read English or Spanish
- Patient Participants ages 2-25 years old
-- Any cancer diagnosis
-- Scheduled to receive CAR T cell therapy
- Caregiver Participants
-- Primary caregiver of a patient 2 to 25 years who is scheduled to receive CAR T cell therapy
- Speak and read English or Spanish
For more information: